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Transition protein 2 (TP2), which is expressed during
stages 12–15 of mammalian spermiogenesis, has been
shown to undergo phosphorylation immediately after
its synthesis. We reported earlier that TP2 is phospho-
rylated in vitro at threonine 101 and serine 109 by the
salt extract of sonication-resistant (elongating and elon-
gated) spermatid nuclei and the protein kinase phos-
phorylating TP2 was identified to be protein kinase A
(PKA). We now report that the cytosol from haploid
spermatids but not from premeiotic germ cells is able to
phosphorylate recombinant TP2 in vitro at threonine
101 and serine 109. The kinase present in the haploid
spermatid cytosol that phosphorylates TP2 has been
identified to be the sperm-specific isoform of protein
kinase A (Cs-PKA). Reverse transcription-PCR analysis
indicated that Cs-PKA was present in the haploid sper-
matids and absent from premeiotic germ cells. The rat
Cs-PKA transcript was amplified and sequenced using
the isoform-specific primers. The sequence of rat Cs-
PKA at the N terminus differs from mouse and human by
one amino acid. Western blot analysis using specific anti-
C1 antibodies revealed that C1-PKA is absent in hap-
loid spermatid cytosol. We have also established an in
vitro nuclear transport assay for the haploid round sper-
matids. Using this assay, we have found that the cyto-
plasmic factors and ATP are absolutely essential for
translocation of TP2 into the nucleus. Phosphorylation
was found to positively modulate the NLS dependent
import of TP2 into the nucleus.
The process of spermiogenesis in mammals, wherein the
haploid round spermatids mature into highly condensed sper-
matozoa, can be broadly divided into three phases. In the first
phase, encompassing stages 1–10, the round spermatids are
transcriptionally active and contain nucleosomal chromatin.
The second phase (stages 12–15) involves the replacement of
nucleosomal histones by transition proteins TP1, TP2, and
TP4.1 Finally, in the third phase, the transition proteins are
replaced by protamines P1 and P2 during stages 16–19 (1, 2).
It is quite interesting to note that the transformation of nucle-
ohistone type of chromatin into nucleoprotamine fiber is not
complete, and 10–15% of sperm chromatin retains nucleoso-
mal histones, probably in the context of nucleosomal structure
(3–7). These unexpected observations have raised several in-
teresting questions as to the nature of chromatin domains,
which resist this replacement process, and the possible signif-
icance of the chromatin domains that retain nucleosomal struc-
ture during early embryonic development. Over the last several
years, we have been studying the DNA binding and condensing
properties of the spermatid protein TP2 and have described in
detail its molecular anatomy with respect to the nature and
identity of novel zinc finger domains, the nuclear localization
signal, and also the role of phosphorylation in DNA condensa-
tion (8, 9). Based on our earlier observations, we have proposed
a model describing the possible sequence of events from the
time of TP2 synthesis in the cytoplasm and subsequent initia-
tion of chromatin condensation upon deposition on chromatin,
implicating distinct roles for the phosphorylation event and
zinc finger domains (9). According to this model, phosphoryla-
tion of TP2 at its C-terminal basic domain prevents the prema-
ture condensation of DNA, which allows the protein to scan the
entire genome and bind to GC-rich sequences. Subsequent de-
phosphorylation at the basic domain leads to the initiation of
chromatin condensation.
Meistrich’s group has generated knockout mice for both TP1
and TP2, and they have observed abnormal chromatin conden-
sation in sperm isolated from the knockout mice (10, 11). More
recently, they have also generated TP1//TP2/ double-
knockout mice, which are infertile.2 These phenotypes of the
knockout mice stress the biological importance of the two pro-
teins in mammalian spermatogenesis, particularly in the glo-
bal chromatin remodeling process. In our previous study, we
mapped, by site-directed mutagenesis, the major phosphoryla-
tion sites in TP2 to Thr-101 and Ser-109 in the C-terminal third
of the protein, which were shown to be phosphorylated by
protein kinase A (8). These experiments were done using the
high salt extract of the sonication-resistant spermatid nuclei,
and the involvement of protein kinase A was further demon-
strated by in vitro experiments employing recombinant TP2
and its phosphorylation-site mutants and purified commercial
protein kinase A. The PKA holoenzyme consists of two catalytic
subunits bound to two regulatory subunits (R2C2). Three genes
encode different isoforms of somatic catalytic subunits. They
are 1) C, which is ubiquitously expressed in most of the
tissues (11–13), 2) C, expressed at lower levels than C in
many tissues (11, 13), and 3) C, which is a transcribed trans-
poson and is expressed only in primate testis (14, 15). More
recently, a sperm-specific isoform of C, termed Cs-PKA, has
been reported (16). Green et al. (17) showed that when the
testicular tubules were labeled with carrier-free [32P]ortho-
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phosphate, the radioactivity associated with TP2 was much
higher in the whole cell extract than that associated with TP2
in sonication-resistant nuclei. They interpreted this observa-
tion to suggest that TP2 undergoes phosphorylation immedi-
ately after its synthesis in the cytoplasm. With this observation
in mind, we were curious to examine the nature of the protein
kinase present in the round spermatid cytoplasm that is in-
volved in TP2 phosphorylation. In the present study, we inves-
tigated this question and demonstrated that the recently dis-
covered sperm-specific isoform of the catalytic subunit of
protein kinase A (Cs-PKA) is involved in the phosphorylation of
TP2. Because the phosphorylation sites happen to be near the
nuclear localization signal of TP2, we also examined the effect
of phosphorylation on its import into the nucleus and found
that the transport is modulated by phosphorylation but is not
required for its import into the nucleus.
EXPERIMENTAL PROCEDURES
Preparation of Round Spermatid Cytosol Extract—Haploid round
spermatids were isolated from adult testicular cells of Wistar rats (60
days old) by the technique of centrifugal elutriation as we have de-
scribed previously (18). The isolated cells were washed in ice-cold phos-
phate-buffered saline, and an aliquot was fixed with ice-cold 70% eth-
anol and stained with ethidium bromide (25 g/ml) to evaluate the
purity by FACS analysis. Cytosol was prepared from round spermatids
and also from the total testicular cells of 25- and 35-day-old rats by
lysing the cells in hypotonic buffer containing 0.75 mM magnesium
acetate, 0.15 mM EGTA, and 3 mM dithiothreitol in 5 mM HEPES buffer,
pH 7.3, supplemented with protease inhibitor mixture (4-(2-aminoeth-
yl)benzenesulfonyl fluoride, E-64, bestatin, leupeptin, pepstatin A, and
aprotinin; 1 g/ml; Sigma) followed by ultracentrifugation at 100,000 
g for 90 min at 4 °C. The cytosol was concentrated by ultrafiltration to
yield a protein concentration of 25–30 g/ml, and aliquots were stored
at 70 °C.
In Vitro and In Gel Kinase Assay—Approximately 6–8 g of cytosolic
proteins and 3 g of recombinant TP2 or GST-2K (containing the PKA
site) were incubated in a buffer containing 20 mM Tris-Cl, pH 7.5, 20 mM
NaCl, 1 mM benzamidine, 10 mM MgCl2, 1 mM phenylmethylsulfonyl
fluoride, and 10 M zinc sulfate for 30 min at 37 °C. 3–5 Ci of
[-32P]ATP was included in all the reactions. For inhibition assays,
increasing amounts of PKI peptide (Sigma) was preincubated with
cytosol before the addition of protein substrate. The reaction was
stopped by the addition of 2 Laemmli SDS-PAGE buffer and heating
at 95 °C for 5 min. The samples were then run on a 15% SDS-PAGE,
stained with Coomassie brilliant blue, destained, dried, and subjected
to autoradiography.
In gel kinase assay was performed as described previously (19, 20)
with minor modifications. Briefly, about 35–40 g of cytosolic protein
from round spermatids was run on a 12% SDS-PAGE with the resolving
gel containing 0.02% recombinant TP2. After the electrophoretic run,
the gel was washed with 50 mM Tris-Cl, pH.8.0, containing 20% propa-
nol and the proteins were subsequently denatured in 50 mM Tris.Cl, pH
8.0, containing 1 mM dithiothreitol and 6 M guanidinium hydrochloride
for 60 min. Proteins were then slowly renatured over a period of 12–16
h with 8–10 changes in a buffer containing 50 mM Tris-Cl, pH 8.0, 1 mM
dithiothreitol, and 0.05% Tween 20. The gel was equilibrated in 1
kinase buffer for 20 min at room temperature and then incubated in the
same buffer containing 10–20 Ci of [-32P]ATP. After washing with
buffer to remove unincorporated ATP, the gel was dried and subjected
to autoradiography. Cytosolic proteins run on a gel without TP2 served
as a negative control.
Western Blot Analysis with Anti-C PKA Antibodies and Analysis of C
1 and Cs-PKA Isoforms by RT-PCR—Cytosolic preparations (6–8 g
protein) from round spermatids and testicular cells from 25- and 35-day-
old rats were run on a 12% SDS-PAGE and electrophoretically transferred
onto a polyvinylidene fluoride membrane. The blotted proteins were
probed using anti-C-PKA antibodies (Calbiochem) raised against an
N-terminal peptide (residues 7 to 21). Anti-rabbit IgG conjugated to horse-
radish peroxidase was used as the secondary antibody with diaminoben-
zamidine as the substrate. For RT-PCR analysis, total RNA was isolated
from round spermatids and testicular cells of 25- and 35-day-old rats
using the TRIzol (Invitrogen) method. Reverse transcription was carried
out using the common reverse primer for both the isoforms C-1 and
Cs-PKA, 5-ACT TTG GTA TGA AGG CTT CCA CCT-3, and the PCR
amplification was done using the isoform-specific forward primers (5-
AACGCCGCCGCCGCCAAGAA-3 for C1-PKA and 5-GTTCTATCTG-
CCCCTACCCTGC-3 for Cs-PKA) and the common reverse primer as
described by San Agustin et al. (16). To obtain 5 end sequences of rat
Cs-PKA, 5-GACTGAGTGATGGCTTCCA-3 was used as the forward
primer and 5-CCTTGAAGGAGAATTCAAGTTTG-3 as the nested re-
verse primer. The DNA sequences of the amplicons were determined in an
ABI 377 automated DNA sequencer (Applied Biosystems).
In Vitro Nuclear Transport—Intracellular transport of exogenously
added recombinant TP2 in vitro with digitonin-permeabilized cells was
studied according to the method of Adam et al. (21) with minor modifica-
tions. Briefly, the round spermatids obtained after centrifugal elutriation
were washed with ice-cold transport buffer, 20 mM HEPES, pH 7.3, 100
mM potassium acetate, 5 mM potassium acetate, 2 mM dithiothreitol, 1 mM
EGTA and protease inhibitor mixture (4-(2-aminoethyl)benzenesulfonyl
fluoride, pepstatinA, E-64, bestatin, leupeptin, and aprotinin; 1 g/ml;
Sigma). The cells were then permeabilized in transport buffer containing
40 g/ml digitonin (Sigma) at 0 °C for 5 min and subsequently washed
with cold transport buffer. 1.5 g of wild-type and phosphorylation-site
mutant TP2 were used for in vitro transport assay. In vitro transport was
initiated in 50 l transport buffer containing cytosol, TP2, and 1 mg/ml
BSA and supplemented with 0.5 mM ATP, 0.5 mM GTP, 5 mM creatine
phosphate, and 20 units/ml creatine phosphokinase. The import reaction
was allowed to proceed for 30 min at 30 °C. In the indicated experiments,
import reaction was carried out in transport buffer in the presence or
absence of ATP regenerating system. Nuclear import assay in cytosol
without supplementing ATP regenerating system was also carried out as
one of the controls. After the import reaction, the cells were washed with
transport buffer, smears were prepared on glass slides, and the localiza-
tion of TP2 was visualized by immunofluorescence using anti-TP2 anti-
body as described previously (7). Where indicated, the cytosol was prein-
cubated with myristoylated PKI (14–22) inhibitor peptide (Calbiochem) for
PKA inhibition in nuclear import assay.
Expression of Wild-Type TP2 and TP2-GFP Fusion Constructs in
HeLa Cells—Rat TP2 cDNA was cloned into pEGFP-C2 vector (BD
Biosciences Clontech) at EcoRI/ApaI sites such that TP2 was fused in
frame at the C terminus of enhanced green fluorescent protein. HeLa
cells were transfected with wild type TP2-cDNA or the fusion GFP-TP2
construct using LipofectAMINE PLUS reagent (Invitrogen) according
to the protocol supplied by the manufacturer. HeLa cells were grown on
cover slips in a 24-well plate in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum at 37 °C in 5% CO2. 24 h
after transfection, the cells were washed with 1Dulbecco’s phosphate-
buffered saline (Sigma) and fixed with 4% paraformaldehyde. Ex-
pressed proteins were visualized in an Axio vision (Carl Zeiss) fluores-
cence microscope.
Immunolocalization of Nucleolin—Localization pattern of nucleolin
in HeLa cells grown on cover slips and elutriated round spermatids was
studied by immunofluorescence, using anti-nucleolin (C23) antibodies
(Santa Cruz Biotechnology). Briefly, the cells were fixed with 4%
paraformaldehyde, permeabilized with 0.1%Triton X-100, blocked with
phosphate-buffered saline containing fetal bovine serum (1%) and
probed with anti-nucleolin antibodies. Donkey anti-goat IgG conjugated
with rhodamine was used as the secondary antibody.
RESULTS
Phosphorylation of TP2 by Round Spermatid Cytosol—We
have shown previously that rat TP2 is phosphorylated in vivo
by metabolic labeling with [32P]orthophosphate and in vitro by
the protein kinase A present in the high salt extract of sonica-
tion-resistant spermatid nuclei (8). The PKA phosphorylation
sites were localized to the C-terminal third of the molecule and
were identified to be Thr-101 and Ser-109, among which Ser-
109 happens to be the predominant site (Fig. 1). Sonication-
resistant spermatid nuclei represent a mixture of both elongat-
ing (stages 12–15) and elongated (stages 16–19) spermatids. As
mentioned earlier above, the two major basic nuclear proteins
present in the elongating spermatids (stages 12–15) are TP1
and TP2 and in the elongated spermatids (stages 16–19) are
protamines P1 and P2. Because the nuclei from which the salt
extract was prepared contain TP2 bound to chromatin, we
believed it necessary to study the phosphorylation of TP2 in the
cytosol of round spermatids, particularly because TP2 is be-
lieved to undergo phosphorylation immediately after its syn-
thesis (17). For this purpose, we have isolated the haploid
round spermatids from total testicular cells by the technique of
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centrifugal elutriation. FACS analysis of the isolated round
spermatids is shown in Fig. 2B. They were 92% pure; the
remaining 8% was contributed by diploid (2N) cells. Fig. 2A
also shows the representation of haploid, diploid, and tet-
raploid cells in the total testicular cells from which round
spermatids were isolated. The results of in vitro kinase exper-
iments with recombinant TP2 as the substrate and cytosol
preparations from round spermatids and total testicular cells
from 25- and 35-day-old rats are shown in Fig. 2C. The germ
cells in the testis of 25-day-old rats represent premeiotic sper-
matogonia and a few early pachytene spermatocytes; those
from 35-day-old rats contain a predominant population of
pachytene spermatocytes (about 30%) and premeiotic germ
cells. Postmeiotic haploid round spermatids appear in the sem-
iniferous tubules of rats at around 40 days. As can be seen from
Fig. 2C, TP2 was phosphorylated only by the round spermatid
cytosol (lane 3) but not by the cytosol preparation of 25- or
35-day-old rat testicular cells (lanes 1 and 2). The figure also
shows that the phosphorylation-site mutant (T101A and
S109A) of TP2 is not phosphorylated by the round spermatid
cytosol. Thus, it is obvious that even the round spermatid
cytosol phosphorylated the same serine and threonine residues
FIG. 1. Schematic representation of
phosphorylation sites in rat TP2. *,
phosphorylation sites at the C-terminal
basic domain; glutamate at the 86th posi-
tion is indicated.
FIG. 2. Isolation of round spermatids and in vitro kinase assay. A, FACS profile of total testicular cells from adult rat. B, FACS profile of
elutriated round spermatids from adult rat. N, haploid cells; 2N, diploid cells; 4N, tetraploid cells. C, in vitro kinase assay of recombinant TP2 (3
g) was carried out as described under “Experimental Procedures,” and the samples were run on SDS-PAGE and subjected to autoradiography.
The lanes indicate kinase assays performed with cytosols (6–8 g) prepared from 25-day-old testicular cells (lane 1), 35-day-old total testicular cells
(lane 2) and elutriated round spermatids (RS) (lanes 3, 4, and 5). Lane 4 is the minus TP2 control, whereas lane 5 shows phosphorylation-site
mutant TP2 (T101A, S109A) used as substrate instead of the wild type TP2. Lane 6 shows recombinant TP2 alone. D, in vitro kinase assay of
GST-2K (3 g) was performed using the cytosols (6–8 g) prepared from 25-day-old rat total testicular cells (lane 1), 35-day-old rat total testicular
cells (lane 2) and elutriated round spermatids (RS) (lanes 3 and 4). Lane 4 is the minus GST-2K control, whereas lane 5 shows GST-2K alone. *,
TP2 and GST-2K bands in C and D, respectively. TP2, 13 kDa (with an anomalous mobility at 20–25 kDa); GST-2K, 27 kDa.
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that we had observed earlier with the salt extract of sonication-
resistant spermatid nuclei. The lack of phosphorylation of TP2
by the cytosol preparation of 25- or 35-day-old rat testicular
cells was rather surprising. To rule out any artifacts in our
assay and also to examine whether these cytosol preparations
contain PKA, we carried out similar assays using GST-2K
(containing PKA site) as the substrate instead of TP2. The
results presented in Fig. 2D clearly demonstrate that GST-2K
is phosphorylated by all the cytosol preparations, indicating
that PKA is indeed present in the cytosols of 25- and 35-day-old
testicular cells but does not phosphorylate exogenously added
TP2. To demonstrate that PKA is phosphorylating TP2 in the
round spermatid cytosol, we carried out phosphorylation assay
in the presence of increasing concentrations of PKI peptide, a
specific inhibitor of PKA. As can be seen in Fig. 3A, there was
a progressive inhibition of phosphorylation of TP2 with increas-
ing concentrations of PKI peptide, thus confirming that PKA
present in round spermatid cytosol is indeed phosphorylating
the TP2. We also carried out in-gel kinase assay to find out the
molecular size of the kinase present in the round spermatid
cytosol that is phosphorylating TP2. The result of such an
experiment showed in Fig. 3B reveals a doublet of around 40
kDa, which agrees with the molecular mass of known PKA
isoforms. Appearance of a doublet probably suggests covalent
modification of the PKA (see below).
Identification of PKA Isoform Present in Round Spermatid
Cytosol—George Witman’s group (16, 22) has identified and
studied the expression pattern of the sperm-specific isoform of
the Cs-PKA in mouse testis. C-1 (somatic) and Cs-PKA
(sperm-specific) isoforms have a stage-specific and mutually
exclusive expression pattern during spermatogenesis in the
mouse. C-1 PKA is expressed only in somatic cells, spermato-
gonia, and preleptotene spermatocytes. The report by San
Agustin et al. (22) shows that C1 disappears from the sper-
matogenic cells coincident with the onset of meiosis. Immuno-
histochemical analysis using anti-mouse Cs-PKA specific anti-
bodies revealed that the maximal expression of Cs isoforms
starts from late pachytene stage spermatocytes. Furthermore,
Cs-PKA has also been shown to be present in the cytoplasm of
round and elongating spermatids (22). They have also shown
that Cs expression is absent in somatic cells and undifferenti-
ated germ cells, including spermatogonia and preleptotene,
leptotene, zygotene, or early pachytene spermatocytes. Cs-PKA
has also been detected in human and pig. These two isoforms
differ from each other in their N-terminal amino acid sequence
(see Fig. 5). Because C1-PKA-specific antibodies are available
(raised against N-terminal peptide residues 7 to 21, which does
not cross react with Cs-PKA), we set out to examine the nature
of PKA present in the cytosol of rat round spermatids. Fig. 4, A
and B, describe the results of Western blot analysis in which it
is clear that the C PKA specific antibodies did not recognize
the PKA present in the round spermatid cytosol, but it did react
with the C1-PKA isoform present in the cytosol of 25- and
35-day-old testicular cells. We then examined the expression
pattern of C1-PKA and Cs-PKA isoform messenger RNA by
RT-PCR analysis using isoform-specific primer sets designed at
the 5-end of their mRNAs (mouse). These results are shown in
Fig. 4, C and D. The transcript corresponding to C1-PKA
isoform (940 bp) was detected only in the testicular cells of 25-
and 35-day-old rats but not in round spermatids of rat. On the
other hand, the Cs-PKA isoform (1.2 kb) transcript was de-
tected only in round spermatids. Thus, these results confirm
the mutually exclusive expression pattern of C1 and Cs-PKA
in rat germ cells that has also been reported in the case of
mouse, ovine, and human (16, 22). Furthermore, these results
also suggest that Cs-PKA is responsible for TP2 phosphoryla-
tion in round spermatid cytosol. The C1 and Cs-PKA isoforms
in mouse also differ in the type of covalent modifications at
their N termini (acetylation in the case of Cs-PKA and myri-
stylation of C1-PKA). This N-terminal covalent modification
FIG. 3. Inhibition of in vitro kinase assay by PKA inhibitor peptide and In-gel kinase assay. A, in vitro kinase assay of recombinant wild
type TP2 (3 g) was carried out as described under “Experimental Procedures,” and the samples were run on SDS-PAGE and subjected to
autoradiography. Lanes 1–5 represent kinase assays performed with cytosol (6–8 g) prepared from elutriated round spermatids (RS) in the
presence of increasing amounts of PKI peptide (specific inhibitor of the catalytic subunit of PKA). Lane 6 indicates the assay performed in the
absence of the inhibitor peptide, whereas lane 7 shows the mobility of recombinant wild type TP2. B, in-gel kinase assay was carried as mentioned
under “Experimental Procedures” using round spermatid cytosol (30–40 g) as the source of kinase and recombinant, wild-type, unphosphorylated
TP2 (0.02% in the resolving gel) as the substrate. The autoradiogram shows a 40-kDa band, which lights up in the RS lane, indicating the molecular
mass of the kinase that phosphorylates TP2. M, protein molecular mass markers. *, covalently modified PKA.
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might explain the doublet we observed in in-gel kinase assay
(Fig. 3B). A striking observation that can be noticed in the
present study is that the recombinant TP2 was not phospho-
rylated by the cytosols of 25- and 35-day-old rat testicular cells
even though they do contain C1-PKA.
We have also amplified the entire open reading frame of the
rat Cs-PKA isoform and determined its complete nucleotide
sequence, which has been submitted to GenBank. The se-
quence at the 5 end and the derived amino acid sequence of rat
Cs-PKA isoform are shown in Fig. 5 along with the correspond-
ing sequences of mouse, ovine, and human Cs-PKA and the
somatic isoform C1-PKA. In all of these species, the first 15
amino acids of the N terminus of C1PKA are replaced by a
seven-amino acid stretch in the Cs-PKA isoform. It is interest-
ing to note that there is a single nucleotide substitution in the
Cs-PKA isoform of all four species at different positions, result-
ing in a change of one amino acid residue. San Agustin et al.
(16, 22) observed that antibodies against the Cs-PKA isoform of
mouse (raised against residues 1 to 7) did not cross-react with
the Cs-PKA isoform of ovine, probably because of this single
amino acid change. They have also shown that the C1-PKA
and Cs-PKA isoform mRNAs are generated by the mechanism
of alternate transcription start sites (16), and the two diverse
first exons are joined into the rest of the open reading frame.
The nucleotide sequence of rat Cs-PKA and Cs-PKA of mouse,
human, and pig beyond the first seven amino acids were found
to be identical to that of C1-PKA.
In Vitro Import of TP2 into Round Spermatid Nucleus and
Effect of Phosphorylation—Phosphorylation of many nuclear
proteins plays an important role in their import from the cyto-
plasm, particularly modulating the function of NLS (23–26).
We have identified previously that the NLS sequence of TP2
resides between the residues 87 and 95 belonging to the class of
monopartite module that is present in SV40 T antigen. Because
phosphorylation by protein kinase Cs-PKA isoform takes place
on Thr-101 and Ser-109, which are 10 residues immediately
downstream of the NLS sequence, we were curious to know the
effect of phosphorylation, if any, on the import of TP2 into the
round spermatid nucleus. Normally, these experiments are
done after transient transfection of the desired construct in the
respective cell lines. However, we were unsuccessful in estab-
lishing a working transfection protocol for round spermatids
using the now well-established procedures for various cell
lines. Furthermore, there is also no report in the literature
describing such a procedure. Therefore, we resorted to the
alternate approach of using nuclear import assay with digito-
nin-permeabilized round spermatids, which have been used
extensively in the literature to understand the mechanism of
nuclear import (21). In these assays, we have monitored the
import of exogenously added recombinant wild-type TP2 and
its phosphorylation-site mutant by indirect immunofluores-
cence. The results of these experiments are presented in Fig. 6.
Fig. 6, B–G, shows the immunofluorescence pattern of the
localization of exogenously added recombinant TP2. When per-
meabilized round spermatids were incubated with transport
buffer alone in the absence and presence of the ATP regener-
ating system, respectively, the protein was localized in the form
of a ring decorating the outer membrane of the nuclear enve-
FIG. 4. Western-blot and RT-PCR
analysis of C 1-PKA and Cs-PKA.
Western blot analysis and RT-PCR anal-
ysis were carried out to identify the ki-
nase involved in the phosphorylation of
TP2 and to study the expression patterns
of C1 and Cs-PKA isoforms. A, Coomas-
sie blue-stained SDS-PAGE image of the
cytosolic extracts (6–8 g). B, Immuno-
blot using anti-C PKA antibodies. Lane
1, 25-day-old rat testis cytosol; lane 2, 35-
day-old rat testis cytosol; lane 3, round
spermatid cytosol; lane 4, pre-stained mo-
lecular mass markers. C and D, RT-PCR
analysis. C, RT-PCR with C 1-PKA spe-
cific upstream and common downstream
primers (see “Experimental Procedures”)
amplifying a 940-bp product. D, RT-PCR
with Cs-PKA-specific upstream and com-
mon downstream primers amplifying a
1.2-kb product. 25d, 35d, and RS indicate
the RNA samples from 25-day-old rat tes-
tis, 35-day-old rat testis, and round sper-
matids respectively. M, molecular size
markers.
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lope. However, when the same transport assay was done in the
presence of cytosolic proteins, TP2 was translocated into the
nucleus (Fig. 6E). This nuclear import of TP2 in the presence of
cytosol is dependent on the presence of ATP regenerating sys-
tem (Fig. 6D). These experiments clearly demonstrate that
transport of TP2 into the round spermatid nucleus is mediated
by cytoplasmic protein components and is energy-dependent.
We would also like to draw attention here to the nature of
fluorescence pattern (foci) observed within the round spermatid
nucleus in our import assay (Fig. 6E). We had shown earlier, in
transient transfection assays, that TP2 preferentially localizes to
nucleolus in COS-7 cells. Just to make sure that preferential
localization to nucleolus is not an isolated observation, we have
repeated transfection assays with HeLa cells and find that even
in HeLa cells, TP2 preferentially localizes to nucleoli (Fig. 6H).
Furthermore, even the TP2-GFP fusion protein localizes prefer-
entially to nucleoli in HeLa cells (Fig. 6I), ruling out artifacts
caused by immunofluorescence procedures. Nucleoli have been
speculated to be inactive in round spermatids and to disassemble
during the elongation phase when transition proteins are ex-
pressed during spermiogenesis. Immunolocalization of nucleolin
was studied, using anti-nucleolin antibody, in HeLa cells (Fig.
6J) and elutriated round spermatids (Fig. 6K). As can be seen
from the figure, although nucleoli were seen in HeLa cells (Fig.
6J), such nucleolar structures were not observed in the round
spermatid nucleus (Fig. 6K). This indicates that the foci seen in
the case of wild-type TP2, within the round spermatid nucleus,
are not nucleoli and might probably represent preferential local-
ization of TP2 to GC-rich DNA.
After establishing the import assay with wild type TP2, we
carried out the assay with the double phosphorylation-site
(T101A, S109A) mutant of TP2. The immunofluorescence pat-
tern of localization of mutant TP2 is shown in Fig. 6F. Two
important observations can be noted from this immunofluores-
cence pattern. First, the cytoplasmic distribution of TP2 is
quite different from that of wild type TP2 (Fig. 6E). No defin-
itive foci were observed in phosphorylation-site mutant TP2, as
in the case of wild-type TP2, and most of the protein was
localized around the nuclear envelope, as was observed with
minus cytosol control (Fig. 6C). A second important observation
was that there were also no definite foci of phosphorylation-site
mutant TP2 localization within the nucleus, as observed with
wild-type TP2. Furthermore, the fluorescence pattern of phos-
phorylation-site mutant TP2 in the nucleus is much more dif-
fuse than the wild-type TP2. We have also done the import
experiment with wild-type TP2 in the presence of 50 M PKI,
an inhibitor of protein kinase A. As can be seen from G of Fig.
6, the fluorescence pattern showed an intense decoration
around the nuclear envelope, which was very similar to that of
the phosphorylation site mutant TP2. The cytoplasmic distri-
bution as well as nuclear distribution was much less defined
compared with the wild-type TP2. Taken together, the results
of these two experiments indicate that phosphorylation posi-
tively modulates the NLS-dependent transport of TP2 into the
round spermatid nucleus, as in the case of SV40 T antigen (25,
26). We have also done this import assay for shorter incuba-
tions (5, 10, and 15 min) and have observed similar differences
in the fluorescence pattern of wild-type TP2 and phosphoryla-
tion site mutant TP2 (data not shown).
DISCUSSION
In the present study, we demonstrated that rat spermatide
protein TP2 is phosphorylated at Thr-101 and Ser-109 residues
by the sperm-specific PKA isoform, Cs-PKA, present in the
cytoplasm of haploid round spermatids. The expression pat-
terns of the somatic isoform C1 and the sperm-specific isoform
Cs-PKA during rat spermatogenesis agrees with the pattern
observed in mouse (16, 22). The activated form of Cs-PKA has
also been detected in the sperm tail and is believed to be
necessary for motility of sperm. However, it is not detected in
ovaries and is hence male-specific. A striking observation made
in the present study is that the C1-PKA present in the cytosol
of 25- and 35-day-old rat testicular cells did not phosphorylate
recombinant TP2. This result must be viewed in the context of
our previous demonstration that TP2 can be phosphorylated in
vitro by purified commercial PKA (8). It is quite likely that the
different isoforms of PKA might exist as multiprotein com-
plexes in vivo, as with A-kinase anchoring proteins, which may
FIG. 5. Comparison of the nucleotide and N-terminal amino acid sequences of mosue, rat, ovine, and human Cs PKAs and rat C
1 PKA. The mouse, ovine, and human Cs-PKA sequences were obtained from San Agustin et al. (2000). The non-consensus nucleotide and amino
acid residues in mouse, ovine, and human Cs-PKA are highlighted. The rat Cs-PKA transcript was amplified; the sequence was determined and
submitted to GenBank (GenBank accession number AY375243). The residues in rat Cs-PKA indicate the consensus sequence, which are
underlined. The identical amino acids in rat Cs-PKA and C 1-PKA are indicated in a smaller font.
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actually determine substrate specificity of phosphorylation. In
this context, sperm-specific A-kinase anchoring proteins have
also been recently reported in the literature (27, 28).
We have also established, in the present study, an in vitro
import assay for studying the uptake of nuclear proteins into
the haploid round spermatids. These experiments clearly dem-
onstrate that transport of TP2 into the round spermatid nu-
cleus is mediated by cytoplasmic protein components and is
energy-dependent. It is now fairly well established that nuclear
import of proteins is a two-step process involving a dimeric
complex of importin /, of which the -subunit binds directly
the NLS motif and serves as the adaptor to importin (29, 30).
However, there are some exceptions, where importin  binds
directly to an NLS sequence. The NLS-protein complexes docks
onto nuclear pore complexes via importin  and are translo-
cated through the nuclear pore in an energy-dependent man-
ner. After translocation, high levels of Ran GTP in the nucle-
oplasm promote cargo release from the importin complex (31,
32). The fluorescence pattern of TP2 in the cytoplasm of round
spermatids (Fig. 6D), showing a defined distribution pattern,
might represent the TP2-importin adapter complexes. It re-
mains to be seen whether TP2 forms a complex with importin
/ heterodimer or interacts directly with importin . An iso-
form belonging to importin  superfamily, Importin 7, has been
shown to be involved in the nuclear import and chaperoning of
basic, nucleic acid binding proteins, such as ribosomal proteins
and histome H1 (33–35). It is generally believed that proteins
larger than 45 kDa require a NLS to be targeted to the nucleus
and proteins of lower molecular mass can diffuse into the
nucleus. However, studies on import of histone H1 (34, 36, 37)
and ribosomal proteins (33, 38, 39) have indicated that proteins
and RNAs that need to be translocated into the nucleus depend
on specific carrier systems, even if they are small enough for
passive diffusion. It has also been hypothesized that such nu-
clear import mechanisms evolved to prevent undesired inter-
actions before the cargo reaches its final destination. Such
mechanisms have been specifically implicated for very basic
proteins, such as histones or ribosomal proteins, which have a
high tendency to precipitate and aggregate at physiological salt
concentration (34). It is interesting to note that TP2 is a highly
FIG. 6. Immunolocalization pattern
of TP2 after in vitro import assay. The
effect of phosphorylation of TP2 near its
NLS was studied by nuclear import assay
using recombinant wild-type and mutant
TP2 and the cytosol prepared from elutri-
ated round spermatids. A, without recom-
binant TP2; B, wild type TP2 in import
buffer without cytosol and ATP regener-
ating system; C, wild-type TP2 in import
buffer with ATP regenerating system but
without cytosol; D, wild-type TP2 in im-
port buffer with cytosol and without ATP
generating system; E, wild-type TP2 in
import buffer with cytosol and ATP regen-
erating system; F, phosphorylation site
mutant in import buffer with cytosol and
ATP regenerating system; and G, wild-
type TP2 in import buffer with cytosol
(preincubated with 50 M myr-PKI (14–
22) inhibitor peptide) and ATP regenerat-
ing system. H and I, ectopic expression of
wild-type in HeLa cells after transient
transfection. H, wild-type TP2; I, TP2
fused to enhanced green fluorescent pro-
tein (pEGFP-C2-TP2). J and K, immuno-
localization of nucleolin, using anti-
nucleolin antibodies, in HeLa cells (J) and
elutriated round spermatids (K). A merge
of 4,6-diamidino-2-phenylindole and tet-
ramethylrhodamine B isothiocyanate flu-
orescence patterns, and differential inter-
ference contrast (phase contrast) images
are included in J and K. Scale bar, 8 m
for A–C and E–K and 10 m for D. Images
in A–G, J, and K were obtained in Leica
Confocal microscope LCS NT, whereas
images in H and I were obtained in Axio
vision fluorescence microscope (Carl
Zeiss) using standard filters.
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basic protein and has a molecular mass of only 13 kDa, but it
still has a defined NLS and a requirement of cytoplasmic com-
ponents for its import into the nucleus, indicating that it is a
regulated process. Hence, it can be speculated that even though
TP2 is relatively small, it needs an efficient nuclear transport
mechanism to ensure that it reaches its final destination and is
not misdirected (see below). These questions are being ad-
dressed in a separate study and will be reported elsewhere.
The subnuclear foci of TP2 localization in round spermatids
did not reveal the nucleolus-specific localization pattern that
we had observed earlier in COS-7 cells (7). We have now shown
that the nucleolar preference of localization was not an isolated
observation with COS-7 cells but was also observed in HeLa
cells using both wild-type TP2 and TP2-GFP fusion constructs
(Fig. 6, H and I). The absence of nucleolin staining in round
spermatids clearly indicated the absence of active nucleolar
structures in these cells (Fig. 6K). Lack of such a preferential
localization in nucleolus in round spermatid nucleus was ini-
tially surprising and puzzling. Earlier studies had assumed
that haploid spermatids are inactive in pol II transcription and
that all the mRNAs are presynthesized during the meiotic
prophase (pachytene) interval. However, it is now clear that
haploid spermatids are active in RNA polymerase II transcrip-
tion (40). However, a systematic study of rDNA transcription
has not been made; hence, the lack of pol I-mediated transcrip-
tion in haploid spermatids needs to be documented. Even
though nucleoli are defined organelles in a eukaryotic nucleus,
there is no physical barrier between the nucleoplasm and nu-
cleolar structure in the form of a lipid bilayer membrane.
Nucleolar assembly is believed to be initiated by coalescence of
the different rDNA repeats and a set of nucleolus-specific pro-
teins (41). In the absence of such a defined organellar struc-
ture, the rRNA cistrons will be distributed all over the nucleus
in round spermatid nuclei. It will be interesting to see whether
TP2 bound chromatin domains that are visualized within the
round spermatid nucleus in these import assays represent
rDNA repeats because of their GC-richness. In a separate
study to be reported elsewhere, we have observed, using chro-
matin immunoprecipitation assay, that the endogenous TP2
bound DNA sequences in elongating spermatids (stages 12 to
15) are indeed GC-rich.
The import assay experiments reported here have also dem-
onstrated that the import of wild type TP2 in the presence of
PKI-inhibitor peptide or the phosphorylation-site mutant
(T101A, S109A) of TP2 is not as efficient as that of wild type TP2,
suggesting that the NLS of TP2 might belong to the class of
phosphorylation-regulated NLS, proteins that are modulated by
a set of sequence motifs. For example, the CcN-motif of SV40 T
antigen is regulated by dual phosphorylation by protein kinase
CK2 and the cyclin-dependent kinase cdc2 (25, 26). Substitution
of CK2 site by the PKA site also caused it to be regulated by
PKA-mediated phosphorylation, indicating that this regulation is
not kinase specific (42). As against the positive modulation of
NLS function, an example of negative regulation of an NLS by
phosphorylation is the cyclin-dependent kinase site-mediated in-
hibition of yeast TFSW15 (23). It is quite likely that such regu-
lation of transport by phosphorylation might be influenced
through the interaction of the cargo with the importin complexes
in the cytoplasm. The presence of monopartite NLS in TP2 and
the positive modulation of the NLS-dependent nuclear import by
a phosphorylation event is very similar to that observed in the
case of SV40 T antigen. Thus, the phosphorylation of TP2 seems
to have an additional role in addition to the chromatin function,
as has been proposed in our model (8). In this model, we proposed
that phosphorylation of the basic domain of TP2 temporarily
masks its condensation property to facilitate the zinc fingers to
recognize and dock onto the CpG dinucleotides in chromatin. A
similar phosphorylation-dephosphorylation event has been pro-
posed for protamine deposition on sperm chromatin (43). Our
model also predicts that a phosphatase should be present in
elongating spermatid nucleus to dephosphorylate TP2 and to
initiate chromatin condensation. In this context, it is worth men-
tioning that Varmuza et al. (44) have reported that the protein
phosphatase 1c gene is specifically expressed in round sperma-
tids, and mice homozygous for targeted insertion within this gene
are infertile.
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